ArticleAmerican journal of translational research2026
Obstructive sleep apnea contributes to coronary artery disease development and poor prognosis.
Article in American journal of translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the correlation between obstructive sleep apnea (OSA) and the incidence of coronary heart disease (CHD), as well as the impact of OSA severity on the short-term outcomes of CHD patients.
methodsA retrospective analysis was conducted on 78 CHD patients admitted to Zhejiang Provincial People's Hospital from January 2022 to December 2024, with another 78 subjects who underwent health checkups in the same hospital during the same period enrolled as the control group. The prevalence of OSA and baseline data were compared between the two groups. Meanwhile, CHD patients were divided into the mild-to-moderate (n = 26) and severe (n = 19) OSA groups according to OSA severity. Baseline data of patients in different subgroups were compared, and all patients were followed up. The incidence of adverse cardiovascular events was recorded and analyzed.
resultsThe CHD group had higher incidences of OSA, hypertension, dyslipidemia and diabetes compared to the control group (all P < 0.05). Multivariate analysis identified these factors as independent risk factors for CHD. A predictive model constructed based on these factors showed good performance with an AUC of 0.638. Further analysis revealed that patients with severe OSA had higher levels of peripheral hemoglobin and IL-6, higher incidence of coagulation dysfunction and diabetes mellitus than those with mild-to-moderate OSA (all P < 0.05).
conclusionOSA is closely associated with the occurrence of CHD, and the predictive model established by combining OSA with other baseline data has favorable predictive efficacy for CHD. In addition, OSA severity exerts a notable impact on the prognosis of CHD patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.